burkholderia
pseudomallei
gramneg
bacterium
found
water
wet
soil
endem
area
border
equat
particularli
southeast
asia
northern
australia
organ
infect
mammal
caus
diseas
melioidosi
human
clinic
manifest
vari
greatli
may
present
flulik
symptom
benign
pneumon
acutechron
pneumonia
fulmin
septicemia
infect
gener
occur
via
inhal
aerosol
skin
abras
risk
contract
diseas
proport
concentr
b
pseudomallei
soil
water
endem
area
heavi
rainfal
result
shift
percutan
inocul
inhal
primari
mode
infect
also
lead
sever
ill
melioidosi
commonli
affect
lung
character
spread
seed
bacteria
spleen
liver
lymph
node
incub
period
clearli
defin
may
rang
day
mani
year
risk
factor
includ
diabet
mellitu
alcohol
cirrhosi
thalassemia
chronic
lung
diseas
infect
patient
becom
bacterem
mortal
rate
remain
high
despit
aggress
antimicrobi
therapi
burkholderia
pseudomallei
refractori
antibiot
resist
mechan
includ
efflux
pump
recommend
treatment
melioidosi
entail
use
ceftazidim
meropenem
intens
phase
tmpsmx
coamoxiclav
erad
phase
sever
month
respons
treatment
slow
erad
b
pseudomallei
difficult
achiev
result
recrudesc
though
consid
exot
us
european
countri
b
pseudomallei
lead
caus
sepsi
bacterem
pneumonia
endem
area
melioidosi
recogn
emerg
infecti
diseas
mani
tropic
region
world
burkholderia
mallei
nonmotil
hostadapt
clone
b
pseudomallei
persist
outsid
equin
reservoir
endem
part
asia
africa
middl
east
south
america
burkholderia
mallei
caus
highli
contagi
zoonot
diseas
glander
primarili
affect
hors
mule
donkey
human
infect
gener
occur
contact
infect
anim
via
cutan
respiratori
rout
diseas
progress
patholog
human
hors
similar
though
clinic
present
case
speci
even
relat
direct
transmiss
may
vari
clinic
manifest
includ
febril
pneumonia
necrosi
tracheobronchi
tree
pustular
skin
lesion
develop
multipl
abscess
aka
farci
patient
becom
bacterem
b
mallei
dissemin
liver
spleen
lymph
node
rapidli
caus
necrosi
cours
diseas
may
rang
acut
rapidli
fatal
slow
protract
altern
remiss
exacerb
even
antibiot
treatment
mortal
rate
human
glander
like
b
pseudomallei
b
mallei
resist
antibiot
concern
b
mallei
b
pseudomallei
may
use
agent
biolog
warfar
especi
sinc
b
mallei
alreadi
util
manner
burkholderia
pseudomallei
studi
us
russia
potenti
bioweapon
never
use
capac
howev
eas
acquir
b
pseudomallei
environ
coupl
resist
antibiot
sever
ill
upon
aerosol
inocul
difficulti
diagnosi
persist
host
make
possibl
seriou
concern
organ
cultur
concentr
deliv
aerosol
signific
casualti
would
ensu
reason
us
feder
select
agent
program
classifi
b
pseudomallei
b
mallei
tier
agent
develop
countermeasur
prioriti
protect
pulmonari
form
glander
melioidosi
particular
interest
lung
like
portal
entri
organ
biolog
attack
commonli
use
surrog
studi
b
mallei
b
pseudomallei
mous
intranas
inocul
gener
util
model
aerosol
rout
infect
method
quick
costeffect
reli
mous
breath
agent
henc
mimick
natur
rout
aerosol
infect
human
diseas
avail
transgen
strain
wealth
murin
immunolog
tool
provid
power
platform
studi
understand
pathogenesi
organ
develop
antiinfect
approach
howev
unlik
human
mice
oblig
nasal
breather
possess
greater
surfac
area
upper
respiratori
tract
addit
enhanc
olfactori
sens
consequ
intranas
inocul
result
signific
proport
inoculum
remain
nasal
passag
reach
lung
lead
high
rate
infect
nasal
associ
lymphoid
tissu
central
nervou
system
via
olfactori
tissu
common
human
moreov
intranas
inocul
entail
inhal
liquid
suspens
smallaerosol
particl
wholebodi
noseonli
aerosol
exposur
model
util
studi
b
mallei
b
pseudomallei
though
platform
deliv
small
aerosol
particl
depend
normal
mous
breath
agent
nasal
passageway
favor
aforement
altern
portal
entri
bodi
furthermor
wholebodi
noseonli
exposur
model
requir
special
equip
dedic
laboratori
space
costprohibit
practic
research
facil
aim
studi
develop
noninvas
rapid
reproduc
practic
safe
aerosol
deliveri
method
studi
pulmonari
form
glander
melioidosi
balbc
mice
without
potenti
mislead
effect
infect
nasal
associ
lymphoid
tissu
central
nervou
system
model
could
use
investig
pathogenesi
b
pseudomallei
b
mallei
aid
develop
relev
countermeasur
highli
pathogen
organ
escherichia
coli
cultur
use
luriabertani
lb
medium
fisher
bioreag
supplement
chloramphenicol
burkholderia
pseudomallei
strain
grown
tryptic
soy
agar
tsa
bd
hour
prior
infect
blood
bronchoalveolar
lavag
tissu
homogen
mice
infect
b
pseudomallei
plate
tsa
contain
polymyxin
b
agar
plate
incub
hour
order
count
coloni
calcul
bacteri
load
tissu
burkholderia
mallei
strain
routin
cultur
brucella
broth
agar
supplement
volvol
glycerol
bag
prepar
inoculum
infect
b
mallei
grown
bag
hour
homogen
tissu
lavag
fluid
blood
infect
mice
spread
onto
bag
supplement
polymixin
b
incub
hour
determin
number
viabl
b
mallei
bacteria
tissu
experi
live
b
pseudomallei
b
mallei
perform
insid
class
ii
biosafeti
cabinet
laboratori
complianc
rule
regul
us
feder
select
agent
program
femal
balbc
mice
week
age
purchas
frederick
nation
laboratori
cancer
research
inocul
mice
anesthet
inject
tribromoethanol
intraperiton
dose
mgkg
anesthet
mice
place
back
special
design
workstand
inclin
angl
hallowel
emc
workstand
outfit
nylon
wire
suspend
anim
upper
teeth
later
barrier
minim
movement
inocul
next
fiber
optic
arm
equip
light
sourc
fisher
scientif
place
front
throat
suspend
anim
order
visual
tracheal
open
mouth
mous
open
tongu
move
side
forcep
modifi
pediatr
otoscop
braintre
scientif
inc
use
guid
blunt
needl
portion
model
insid
tracheal
open
vocal
cord
total
bacteri
suspens
subsequ
deliv
lung
use
gastight
highpressur
syring
compon
devic
burkholderia
pseudomallei
b
mallei
bacteria
use
inocul
mice
cultur
agar
plate
suspend
phosphatebuff
salin
pb
optic
densiti
klett
unit
use
colorimet
correspond
coloni
form
unit
cfu
per
ml
bacteri
suspens
serial
dilut
aliquot
immedi
spread
onto
agar
plate
determin
number
cfu
present
inoculum
backtitr
inoculum
perform
challeng
experi
infect
mice
monitor
twice
daili
clinic
sign
ill
period
day
indic
experiment
end
point
anim
anesthet
euthan
tissu
blood
lung
spleen
asept
collect
homogen
dispos
tissu
grinder
serial
dilut
plate
agar
medium
calcul
bacteri
load
surviv
data
analyz
use
kaplanmei
method
valu
calcul
accord
reed
muench
infect
anim
monitor
twice
daili
human
endpoint
strictli
observ
mice
exhibit
sign
moder
sever
discomfort
euthan
accomplish
anesthet
anim
tribromoethanol
follow
cervic
disloc
procedur
accord
avma
guidelin
euthanasia
follow
grade
system
use
determin
euthanasia
appropri
weight
loss
point
bodi
condit
rough
coat
emaci
evid
segment
vertebr
column
andor
dorsal
pelvic
bone
readili
palpabl
point
moder
dyspnea
base
thorac
movement
respiratori
rate
point
hunch
back
point
failur
respond
stimuli
point
conjunct
eye
swell
shut
appar
ophthalm
discharg
point
anim
point
score
human
euthan
pain
suffer
anim
minim
perform
procedur
anesthesia
observ
aforement
human
endpoint
food
water
provid
ad
libitum
analges
use
may
affect
experiment
outcom
studi
investig
patholog
chang
induc
organ
lung
bronchoalveolar
lavag
cell
collect
inspect
microscopi
anesthesia
trachea
mice
expos
incis
made
midlin
blunt
end
needl
next
insert
tracheal
incis
use
syring
steril
salin
infus
lung
fluid
recov
gentl
suction
bronchoalveolar
lavag
fluid
balf
process
within
hr
collect
insur
cell
morpholog
maintain
specif
aliquot
place
well
duplic
dispos
sampl
concentr
contain
slide
balf
centrifug
use
cytofug
sampl
process
slide
remov
cell
concentr
airdri
fix
immers
anhydr
methanol
stain
modifi
wrightgiemsa
use
autom
hematolog
slide
stainer
biomed
system
sampl
examin
boardelig
veterinari
clinic
pathologist
cytolog
evalu
perform
microscopi
use
olympu
microscop
olympu
corpor
imag
captur
use
olympu
camera
softwar
olympu
corpor
standard
molecular
biolog
techniqu
perform
describ
elsewher
genom
dna
obtain
plategrown
bacteria
use
kit
life
platinum
pfx
dna
polymeras
use
clone
experi
per
manufactur
recommend
life
amplicon
encompass
amino
acid
aa
b
pseudomallei
boaa
protein
genbank
access
number
gener
primer
cgc
cac
gtg
aat
ggg
acc
gtc
aac
tcg
pmli
site
underlin
ggt
taa
tta
aag
att
agt
gat
ctt
cac
ggg
paci
site
underlin
dna
fragment
excis
agaros
gel
purifi
high
pure
pcr
product
purif
kit
roch
appli
scienc
restrict
endonucleas
pmli
paci
new
england
inc
ligat
pmli
paci
site
vector
specifi
ntermin
histag
emd
millipor
yield
plasmid
pelhisboaa
plasmid
sequenc
verifi
mutat
introduc
pcr
confirm
protein
express
pelhisboaa
correspond
residu
b
pseudomallei
boaa
join
six
ntermin
histidin
residu
plasmid
dna
use
templat
sequenc
reaction
obtain
qiaprep
spin
miniprep
kit
qiagen
similar
approach
use
obtain
plasmid
express
residu
b
pseudomallei
orf
specifi
residu
b
pseudomallei
orf
pcr
product
clone
amplifi
primer
ccc
aag
ctt
cag
ctt
tac
acg
ctc
cag
hindiii
site
underlin
ggt
taat
taa
agc
aac
tgg
ccg
acg
ttg
ac
paci
site
underlin
ccc
aag
ctt
ggc
gag
aac
gcc
tat
gcc
ggc
hindiii
site
underlin
ggt
taa
tta
aag
gac
ctt
ctg
atc
cgt
gta
ctg
paci
site
underlin
respect
genom
dna
use
templat
pcrbase
clone
experi
design
bpsxxxxxbmaxxxxx
refer
locu
tag
number
orf
studi
annot
genom
sequenc
b
pseudomallei
strain
b
mallei
respect
readili
avail
ncbi
plasmid
sequenc
univers
michigan
sequenc
core
http
seqcorebrcfmedumichedu
chromatogram
analyz
assembl
sequench
softwar
gene
code
corpor
sequenc
analysi
perform
use
vector
nti
life
histag
recombin
protein
obtain
previous
outlin
laboratori
briefli
plasmid
pelhisboaa
introduc
e
coli
strain
emd
millipor
purpos
overexpress
purifi
recombin
protein
express
induc
ad
iptg
final
concentr
mm
broth
cultur
incub
hour
agit
bacteria
pellet
follow
treatment
ht
protein
extract
reagent
emd
millipor
supplement
emd
millipor
recommend
condit
recombin
protein
purifi
use
bind
system
emd
millipor
per
manufactur
instruct
protein
concentr
determin
bicinchonin
acid
bca
protein
assay
kit
thermo
scientif
pierc
donald
e
wood
univers
calgari
kindli
provid
capsular
polysaccharid
cp
oligosaccharid
chain
lp
op
molecul
purifi
b
pseudomallei
strain
cp
mutant
b
pseudomallei
use
purifi
op
lp
mutant
b
pseudomallei
use
purifi
cp
duplic
well
plate
thermo
scientif
nunc
coat
overnight
antigen
excess
unbound
antigen
remov
wash
well
tween
well
fill
tween
contain
wtvol
dri
milk
incub
hour
room
temperatur
wash
tween
well
probe
overnight
primari
antibodi
dilut
tween
dri
milk
incub
well
wash
tween
follow
overnight
incub
secondari
antibodi
conjug
hrp
southernbiotech
dilut
tween
dri
milk
wash
excess
secondari
antibodi
tween
tmb
microwel
peroxidas
substrat
kpl
ad
well
color
develop
indic
antibodi
bind
antigen
measur
determin
absorb
well
content
wavelength
nm
use
micropl
spectrophotomet
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
univers
georgia
institut
anim
care
use
committe
well
institut
biosafeti
committe
effort
made
minim
anim
suffer
statist
analys
perform
use
prism
graphpad
softwar
inc
burkholderia
mallei
b
pseudomallei
infect
gener
occur
via
percutan
inocul
inhal
aerosol
respiratori
rout
infect
ensu
pulmonari
diseas
also
particular
concern
respect
use
b
mallei
b
pseudomallei
agent
biolog
warfar
henc
develop
mous
model
aerosol
inocul
studi
organ
model
entail
use
deliv
bacteria
directli
lung
devic
gener
aerosol
tip
bent
needl
attach
highpressur
stainless
steel
syring
contain
agent
modifi
pediatr
otoscop
use
introduc
needl
part
trachea
anesthet
mice
bacteri
suspens
aerosol
airway
knowledg
inocul
method
report
b
pseudomallei
b
mallei
produc
mist
particl
mean
mass
aerodynam
diamet
aerosol
gener
push
fluid
atom
sapphir
locat
tip
needl
part
devic
test
whether
procedur
affect
viabil
b
pseudomallei
andor
b
mallei
bacteri
suspens
contain
organ
per
ml
load
highpressur
syring
compon
dose
spray
ml
pb
serial
dilut
plate
onto
agar
medium
calcul
number
viabl
bacteria
result
experi
shown
figur
demonstr
use
advers
impact
viabil
agent
experi
also
perform
verifi
number
viabl
organ
deliv
lung
mice
consist
number
bacteria
inoculum
accomplish
plategrown
burkholderia
suspend
pb
concentr
cell
per
ml
seriallydilut
plate
onto
agar
medium
calcul
number
viabl
organ
inoculum
prior
infect
use
deliv
agent
murin
lung
thirti
minut
postinocul
mice
euthan
mice
per
dose
lung
collect
homogen
dilut
plate
agar
medium
determin
bacteri
load
result
experi
shown
figur
indic
number
organ
deposit
lung
equival
inoculum
next
determin
median
lethal
dose
b
pseudomallei
b
mallei
accord
method
reed
muench
cohort
mice
inocul
serial
dilut
organ
use
monitor
clinic
sign
ill
morbid
period
day
base
data
shown
figur
calcul
agent
b
pseudomallei
cfu
b
mallei
valu
strain
consist
publish
report
util
altern
aerosol
deliveri
method
use
intranas
rout
inocul
report
cfu
use
whole
bodi
aerosol
exposur
chamber
produc
valu
organ
b
pseudomallei
model
higher
report
intranas
rout
inocul
whole
bodi
exposur
chamber
calcul
x
cfu
respect
factor
age
weight
mice
bacteria
cultur
prior
infect
ie
broth
versu
plategrown
may
account
differ
intranas
rout
inocul
use
whole
bodi
exposur
chamber
entail
mice
breath
agent
nasal
passag
caus
infect
nasal
associ
lymphoid
tissu
central
nervou
system
addit
pulmonari
diseas
could
contribut
lower
model
intratrach
inocul
circumv
mous
nasal
passageway
may
reduc
potenti
confound
complic
due
infect
nasal
associ
lymphoid
tissu
central
nervou
system
result
higher
valu
b
pseudomallei
clinic
progress
diseas
found
similar
organ
divid
stage
depict
figur
mice
stage
develop
chronic
infect
character
lung
granuloma
spleen
abscess
data
shown
progress
stage
character
conjunct
significantli
reduc
mobil
consider
weight
loss
difficulti
breath
anim
progress
stage
invari
succumb
infect
within
hour
anim
infect
develop
diseas
even
inocul
dose
low
b
pseudomallei
figur
b
mallei
figur
organ
taken
togeth
data
indic
develop
highli
reproduc
sensit
consist
accur
aerosol
inocul
method
studi
b
mallei
b
pseudomallei
infect
examin
kinet
replic
dissemin
mice
challeng
bacteria
correspond
roughli
anim
sacrif
four
differ
time
point
postchalleng
bacteri
load
lung
spleen
blood
determin
addit
lung
collect
inocul
calcul
number
viabl
organ
administ
organ
heavili
infect
b
pseudomallei
b
mallei
lung
figur
postinfect
number
viabl
b
mallei
bacteria
increas
order
magnitud
regardless
dose
use
inocul
anim
figur
thereaft
bacteri
number
continu
increas
albeit
slower
rate
reach
maximum
dose
dose
dose
cfu
burkholderia
pseudomallei
replic
faster
rate
b
mallei
first
infect
bacteri
number
increas
inocul
dose
figur
mice
infect
b
pseudomallei
load
reach
cfu
anim
succumb
infect
time
point
mice
challeng
bacteri
number
rose
nearli
organ
postinfect
contrast
reduct
cfu
measur
time
period
mice
inocul
equival
b
pseudomallei
agent
first
detect
spleen
postchalleng
figur
burkholderia
pseudomallei
dissemin
organ
greater
number
b
mallei
especi
challeng
dose
number
viabl
b
mallei
bacteria
increas
order
magnitud
inocula
figur
thereaft
bacteri
load
anim
infect
reach
plateau
cfu
respect
wherea
number
b
mallei
cell
spleen
mice
challeng
continu
increas
organ
twentyfour
hour
infect
spleen
mice
inocul
b
pseudomallei
heavili
colon
agent
continu
prolifer
nearli
reach
bacteria
postchalleng
bacteri
load
spleen
anim
inocul
increas
point
forward
bacteri
count
remain
constant
mice
infect
steadili
declin
undetect
level
anim
challeng
burkholderia
pseudomallei
first
cultur
bloodstream
postinfect
bacteri
count
proport
number
organ
deliv
lung
figur
presenc
agent
peripher
blood
colon
spleen
commensur
bacteri
number
time
point
figur
suggest
dissemin
via
bloodstream
mice
infect
number
viabl
bacteria
blood
continu
rise
reach
cfuml
experiment
endpoint
figur
though
b
pseudomallei
cultur
bloodstream
anim
infect
first
postchalleng
bacteri
load
peak
cfuml
bacteria
cultur
peripher
blood
thereaft
burkholderia
mallei
recov
blood
postinfect
regardless
dose
use
inocul
anim
figur
organ
first
detect
postinfect
mice
challeng
time
point
anim
inocul
respect
earli
rapid
replic
b
mallei
lung
colon
spleen
figur
absenc
bacteria
bloodstream
specif
time
point
figur
especi
mice
infect
suggest
b
mallei
phagocyt
alveolar
macrophag
dissemin
primarili
via
lymphat
system
hypothesi
support
presenc
phagocytos
bacilli
macrophag
bronchoalveolar
lavag
see
definit
experi
need
determin
precis
mechan
bacteria
dissemin
site
infect
peripher
site
altogeth
experi
demonstr
b
pseudomallei
b
mallei
rapidli
replic
larg
number
lung
dissemin
colon
spleen
within
postinfect
lower
challeng
dose
organ
replic
b
pseudomallei
control
lung
spleen
blood
first
post
infect
correl
mice
develop
chronic
infect
observ
anim
infect
b
mallei
even
though
mice
infect
bacteria
also
develop
chronic
infect
investig
patholog
chang
induc
organ
bronchoalveolar
lavag
fluid
balf
collect
mice
postchalleng
examin
microscopi
portion
fluid
lung
homogen
also
dilut
plate
onto
agar
medium
determin
bacteri
load
figur
anim
infect
bacteria
control
mice
inocul
steril
pb
use
bronchoalveolar
lavag
fluid
control
mice
appear
normal
consist
occasion
cluster
ciliat
columnar
respiratori
epitheli
cell
rare
alveolar
macrophag
figur
inflammatori
infiltr
observ
anim
contrast
balf
mice
infect
b
mallei
b
pseudomallei
inflam
consist
primarili
degener
neutrophil
neutrophil
lost
abil
control
water
homeostasi
swollen
eosinophil
nuclei
activ
macrophag
respiratori
epitheli
cell
degener
neutrophil
form
presenc
bacteri
endotoxin
like
lp
known
perfor
nuclear
cellular
membran
reason
presenc
degener
neutrophil
cytolog
prepar
even
absenc
bacteria
suggest
bacteri
infect
neutrophil
ingest
bacteria
receptormedi
phagocytosi
process
intern
bacteria
within
vacuol
eg
phagosom
ultim
goal
fuse
vacuol
lysosom
bacteria
digest
presenc
extracellular
bacteria
degener
neutrophil
suggest
infect
presenc
intracellular
bacteria
specif
bacteria
contain
within
intracytoplasm
vacuol
indic
bacteri
infect
sever
neutrophil
macrophag
found
contain
phagocytos
bacteria
confirm
activ
infect
balf
infect
mice
also
contain
cellular
debri
free
nuclei
along
presenc
degener
neutrophil
indic
ongo
cell
necrosi
presum
due
bacteri
endotoxin
like
lp
lavag
sampl
appear
hemorrhag
possess
low
moder
number
erythrocyt
red
blood
cell
rbc
andor
macrophag
intracellular
rbc
hemosiderin
pigment
hemoglobin
breakdown
product
rbc
bronchoalveolar
lavag
fluid
mice
infect
organ
possess
greatest
bacteri
burden
mark
pyogranulomat
inflamm
figur
anim
inocul
cfu
display
moder
bacteri
number
degre
inflamm
data
shown
balf
mice
infect
organ
demonstr
intermedi
inflamm
bacteri
burden
figur
overal
cytolog
differ
observ
balf
mice
infect
b
mallei
b
pseudomallei
term
type
magnitud
inflamm
compar
equival
inocul
dose
addit
presenc
hemorrhag
intracellular
bacilli
balf
suggest
organ
may
dissemin
lymphat
hematogen
rout
via
infect
macrophag
extracellular
bacilli
consist
result
depict
figur
time
point
gain
insight
immun
respons
organ
test
survivor
sera
presenc
antibodi
panel
surfaceassoci
burkholderia
antigen
figur
show
infect
mice
produc
antibodi
capsular
polysaccharid
cp
panel
oligosaccharid
chain
lp
op
panel
b
adhesin
boaa
panel
c
predict
autotransport
protein
panel
panel
e
cp
op
abund
immunogen
molecul
surfac
b
pseudomallei
b
mallei
play
critic
role
pathogenesi
mutant
lack
polysaccharid
sever
impair
virul
structur
highli
conserv
throughout
burkholderia
speci
shown
elicit
product
antibodi
human
case
melioidosi
glander
boaa
orf
publish
genom
sequenc
b
pseudomallei
b
mallei
respect
oligomer
autotransport
adhesin
character
laboratori
shown
stimul
strong
antibodi
respons
experiment
equin
glander
hors
natur
host
reservoir
b
mallei
arguabl
relev
surrog
studi
glander
sera
hors
experiment
glander
also
shown
contain
high
antibodi
titer
predict
autotransport
protein
interestingli
latter
also
elicit
robust
antibodi
respons
human
melioidosi
patient
biolog
function
contribut
virul
yet
determin
taken
togeth
data
demonstr
mice
infect
via
aerosol
rout
b
mallei
b
pseudomallei
produc
antibodi
antigen
known
major
target
immun
respons
human
hors
ie
natur
host
infect
immunolog
parallel
underscor
use
relev
model
studi
diseas
highli
pathogen
organ
develop
countermeasur
use
inocul
anim
speci
intratrach
studi
pulmonari
infect
report
sever
agent
includ
aspergillu
fumigatu
rat
monkeypox
nonhuman
primat
coronaviru
rat
mycobacterium
tuberculosi
mice
chlamydophila
pneumonia
mice
studi
first
report
describ
use
devic
studi
b
pseudomallei
b
mallei
result
demonstr
aerosol
deliveri
method
produc
hallmark
melioidosi
glander
low
infecti
lethal
dose
rapid
replic
agent
lung
dissemin
spleen
bacteremia
consist
publish
model
aerosol
infect
organ
intranas
wholebodi
noseonli
aerosol
exposur
use
deliveri
platform
offer
mani
advantag
devic
use
small
volum
accur
deliv
known
number
bacteria
directli
lung
figur
inocul
procedur
also
rapid
routin
infect
mice
less
hour
time
period
encompass
anesthesia
inocul
recoveri
anesthesia
furthermor
model
safe
manipul
perform
insid
biosafeti
cabinet
involv
surgic
procedur
requir
extens
expens
special
equip
consider
particularli
relev
studi
highli
pathogen
organ
contain
prepar
manuscript
revelli
colleagu
publish
report
use
similar
intratrach
inocul
approach
studi
pulmonari
melioidosi
investig
use
whole
bodi
imag
histopatholog
demonstr
mice
inocul
b
pseudomallei
develop
primari
focu
infect
lung
nasal
passag
key
differ
method
deliveri
platform
produc
small
aerosol
particl
revelli
et
al
use
needl
attach
gastight
syring
infus
bacteri
liquid
suspens
trachea
intratrach
inocul
approach
provid
rout
aerosol
infect
circumv
mous
nasal
passageway
reduc
potenti
confound
complic
due
infect
nasal
associ
lymphoid
tissu
central
nervou
system
thu
repres
valuabl
surrog
studi
pulmonari
diseas
caus
b
pseudomallei
b
mallei
